dLocal Ltd has officially announced the details for its 2026 Annual General Meeting (AGM), which is set to take place on December 2, 2026. This meeting will be significant as it will cover essential governance matters, including the appointment of directors and the ratification of financial statements for the fiscal year ending December 31, 2025.
The AGM will be held at 11:00 a.m. Montevideo time (9:00 a.m. New York time) at the company’s offices in Montevideo, Uruguay, and will also be accessible virtually via a live webcast. This hybrid format aims to enhance shareholder participation from various locations.
Background
dLocal Ltd, listed on Nasdaq under the ticker DLO, operates within the Services-Business Services, NEC sector (SIC 7389). The company is known for its innovative payment solutions that facilitate cross-border transactions, particularly in emerging markets. The recent filing, dated November 4, 2026, indicates the company's ongoing efforts to maintain transparency and engage with its shareholders effectively.
What the Filing Says
The filing states, "NOTICE IS HEREBY GIVEN that the 2026 Annual General Meeting... will be held on Wednesday, December 2, 2026..." The agenda includes the appointment of directors, ratification of financial statements, and other business matters.
Impact
This meeting may significantly affect shareholders, as it will include key votes on director appointments and financial approvals. As of the record date, October 23, 2026, there were 286,469,957 common shares outstanding, which includes both Class A and Class B shares, giving a total of 722,322,281 votes eligible for the meeting.
What's Next
In the lead-up to the AGM, shareholders are encouraged to participate virtually and vote on the proposed resolutions. The filing does not specify any further actions following the meeting.
Read Next
Twin Disc to Present New Investor Materials on Nov. 4, 2026
AXS Investments LLC Reports $1 Billion Portfolio in Latest Filing
Creative Financial Designs reports $2.2B in holdings
First Kentucky Securities Corporation Files MA-A Form Update
Septerna selects SEP-204 as development candidate for diseases
Richard C. Young & CO., LTD. reports Q3 2026 holdings









